Mokast LC-SR Tablet is a novel combination medication containing Levocetirizine (5mg) and Montelukast (10mg) in a single tablet formulation. This innovative product is designed to provide dual symptomatic relief for patients suffering from chronic urticaria and allergic rhinitis. Levocetirizine, a potent antihistamine, effectively targets histamine-induced symptoms such as pruritus, erythema, and angioedema, while Montelukast, a leukotriene receptor antagonist, addresses inflammation-mediated responses characterized by bronchospasm, nasal congestion, and ocular itching. The combination of these two medications in Mokast LC-SR Tablet offers enhanced efficacy and improved patient outcomes compared to monotherapy. The once-daily tablet is formulated with a controlled-release mechanism, allowing for sustained delivery of the active ingredients throughout the dosing interval. As a result, patients experience prolonged relief from their symptoms, reduced frequency of dosing, and improved overall quality of life. Mokast LC-SR Tablet is an effective and convenient treatment option for managing chronic urticaria and allergic rhinitis, offering a comprehensive approach to symptom management.